(a) An individual shall be notified of a drug substitution, including an interchangeable biological product, and provided the right to refuse the substitution prior to purchase of the substitute drug product.
(b)(1) The Department of Health shall create and distribute to all pharmacies signs that state in block letters not less than one inch in height: “This pharmacy may substitute a less expensive drug product that is equivalent to the one prescribed by your health care practitioner unless you request otherwise.
(2) Each pharmacy shall display the sign in a prominent place that has a clear and unobstructed public view at or near the place where prescriptions are dispensed.
(Sept. 10, 1976, D.C. Law 1-81, title III, § 301; as added Mar. 11, 2010, D.C. Law 18-118, § 2(d), 57 DCR 901; Oct. 20, 2020, D.C. Law 23-133, § 2(e), 67 DCR 9880.)
Structure District of Columbia Code
Chapter 8 - Prescription Drug Price Information
Subchapter III - Substitution of Therapeutically Equivalent Drugs
§ 48–803.01. Generically equivalent drug formulary; therapeutic interchange list
§ 48–803.02. Dispensing of generically equivalent drug product or interchangeable biological product
§ 48–803.03. Dispensing of substitute drug products — conditions
§ 48–803.03a. Dispensing of substitute drug products by pharmacists — notification of substitution
§ 48–803.04. Dispensation of equivalent products by pharmacists — Recording and labeling required